| |
The National Cancer Institute's (NCI) Office of
Technology and Industrial Relations (OTIR) works to accelerate the pace
of cancer research and the translation of research results into new
therapies, diagnostics, and preventive agents. Located in NCI's Office
of the Director, OTIR encourages new technology development and promotes
collaborations between NCI and the private sector.
This site is designed for technology developers,
private industry, and small businesses. Use it to access information
on NCI funding, resources, discoveries, and scientists.
Cancer Nanotechnology -
Going Small for Big Advances
(699K-PDF) 
Cancer Nanotechnology Symposia
The National Cancer Institute is facilitating
dialogue among the cancer research communities together with technology
developers to focus on the potential of nanotechnology for cancer diagnosis,
treatment, and prevention. In its effort to develop a cancer nanotechnology
plan, the NCI is supporting through host institutions the Cancer Nanotechnology
Symposia series of regional meetings that features presentations by
leading scientists in nanotechnology and cancer research.
- March 3, 2004
Nanoscience: Visualizing and Targeting Cancer
Salk Institute for Biological Studies, La Jolla, CA
- March 4, 2004
Nanotechnology: Enabling Breakthroughs in Cancer Early Detection and
Therapeutics
Fred Hutchinson Cancer Research Center, Seattle, WA
- May 22, 2004
BioNEMS Symposium
University of Southern California, Los Angeles, CA
- August 11-13 , 2004
Lawrence Berkeley National Laboratory and
University of California at San Francisco, San Francisco, CA
- October 27, 2004
The Cleveland Clinic Foundation and
Case Western Reserve University, Cleveland, OH
- Other symposia pending:
Portland, OR
Boston, MA
Washington, DC
|
|
 |
|
|
|
 |
NCI Alliance for Nanotechnology in Cancer
For more information on the NCI's cancer nanotechnology activities, please see
http://nano.cancer.gov |
|
Request for Information:
"CREATING CANCER NANOTECHNOLOGY PLATFORMS THROUGH
DIRECTED RESEARCH PROGRAMS".
NCI is encouraging potential grantees/contractors
to submit ideas about new nanotechnology approaches to cancer diagnosis, treatment,
and prevention to assist the NCI in developing new RFAs, RFPs, and PAs.
Closing date is August 2, 2004. |
|
October 18, 2004, is the next receipt date for the new RFAs for the Innovative Molecular Analysis Technologies (IMAT) Program:
|
|
October 18 , 2004, is the next receipt date for the new SBIR RFAs for the Innovative Molecular Analysis Technologies (IMAT) Program:
|
|
Additional receipt dates in 2005 and 2006 have been posted for the Innovative Molecular Analysis Technologies program. Please see the notice in the NIH Guide. |
|
